Foley Partner Judith Waltz authored an article that appeared in the August 2010 edition of Medical Device and Diagnostic Industry titled “U.S. Focuses Enforcement on Manufacturers.” Waltz discusses increasing healthcare enforcement activity under the Obama administration, stating that the federal government has focused enforcement activity on how providers are billing products to government healthcare programs. She recommends that manufacturers review recent False Claims Act settlements and consider whether further scrutiny of their product support services and pricing strategies may be warranted.
Click here to read the complete article.
Author(s)
Related Insights
21 May 2025
Tariff & International Trade Resource
What Every Multinational Company Should Know About … Customs Enforcement and False Claims Act Risks (Part III)
We complete the series on “Customs Enforcement and False Claims Act Risks” with Part III, which focuses on preparing for the most common FCA risks arising from improper management of import operations.
02 June 2025
Events
Biotech Panel Discussion & Happy Hour
Join Foley & Lardner LLP along with Biotech XYZ for an engaging evening event featuring a dynamic panel discussion and a lively happy hour.
03 June 2025
Events
Biotech Breakfast + Office Hours
Join Foley & Lardner LLP along with Biotech XYZ for Phase Capitals’ flagship networking biotech breakfast and office hours with Q&A sessions.